FDA approval adds a higher concentration–stable formulation of piflufolastat F 18 to support PSMA-PET imaging in initial staging and biochemical recurrence settings. Improved stability is designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results